#Wegovy #NovoNordisk #ObesityTreatment
www.nasdaq.com
FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7. 2 mg) to reduce excess body weight and maintain weight reduction in the long term.
#NovoNordisk #GLP1Drugs #DrugSafety
www.aol.com
FDA: Novo Nordisk failed to report deaths of weight-loss drug patients
The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths.
#Ozempic #NovoNordisk #Lawsuit
www.newsweek.com
Ozempic maker sued after woman died from stomach paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after a woman using the drug died from gastroparesis, a condition also known as stomach paralysis.
#LékyNaHubnutí #NovoNordisk #FDA
www.ceskenoviny.cz
Americký regulátor FDA schválil lék na hubnutí Wegovy ve formě pilulky | ČeskéNoviny.cz
Washington/Kodaň - Americký Úřad pro kontrolu potravin a léčiv (FDA) v pondělí schválil lék na hubnutí Wegovy ve formě pilulky, oznámil dánský výrobce léku, farmaceutická společnost Novo Nordisk.
